Navigation Links
Cerulean Pharma to Present Data on CRLX101's HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
Date:4/4/2013

CAMBRIDGE, Mass., April 4, 2013 /PRNewswire/ -- Cerulean Pharma Inc., a leader in dynamically tumor-targeted nanopharmaceuticals, today announced that researchers will present both pre-clinical and clinical data on Cerulean's Phase 2 candidate, CRLX101, in sessions at the American Association for Cancer Research (AACR) Annual Meeting. Among the findings, Cerulean will share clinical data from a study evaluating synergy between CRLX101 and Avastin® (bevacizumab).

(Logo:  http://photos.prnewswire.com/prnh/20130107/NE37515LOGO )

In multiple animal models, CRLX101 inhibits hypoxia-inducible factor 1a (HIF-1a), which is involved in cancer survival mechanisms, and which is up-regulated in the hypoxic conditions created by anti-angiogenic drugs. Animal models suggest that CRLX101 is synergistic with multiple anti-angiogenic drugs, and this hypothesis is being tested in a clinical trial combining CRLX101 with Avastin, the leading anti-angiogenic medicine.

Dr. Stephen M. Keefe , the Ann B. Young Assistant Professor in Cancer Research at the Perelman School of Medicine at the University of Pennsylvania, will present a poster entitled A Phase Ib-2a Study Evaluating the Nanopharmaceutical CRLX101 in Combination with Bevacizumab (April 9, 8:00 am – 12:00 pm) on a clinical trial studying synergy between CRLX101 and Avastin when combined to treat patients with advanced renal cell carcinoma. Dr. Keefe, who practices at the Abramson Cancer Center of the University of Pennsylvania, will present data showing that the CRLX101-Avastin combination has been well tolerated in six patients treated to date with no dose limiting toxicities observed. Additional patients are being enrolled in the study to confirm combinability and to assess efficacy.

"The pre-clinical data for CRL
'/>"/>

SOURCE Cerulean Pharma Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cerulean Pharmas Lead Candidate Selected as a "Top 10 Oncology Project to Watch"
2. Cerulean Announces First Patient Dosed in Phase 2 Study of CRLX101 in Ovarian Cancer
3. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
4. Valeant Pharmaceuticals Provides Update to Recent Event
5. X-BODY Announces Multi-Million Dollar Development Alliance With Jiangsu Hengrui Medicine Co., Ltd., A Leading Pharmaceutical Company In China, To Develop Novel Therapeutic Antibodies For AMD
6. Oramed Pharmaceuticals Granted Japanese Patent for its Core Technology in Oral Delivery of Proteins
7. Valeant Pharmaceuticals And Obagi Medical Products Agree On An Increased Offer Price Of $24.00 Per Share In Cash
8. DFH Pharma, USA Partners with Hetero Group, INDIA to Develop 2nd Generation HIV Maturation Inhibitor Drugs
9. Collegium Pharmaceutical Names Douglas Carlson to Vice President of Business Development
10. Kentucky Health Cooperative To Partner With ProCare Rx For Pharmacy Benefit Management
11. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... 2015  Columbia Laboratories, Inc. (Nasdaq: CBRX ... a specialty pharmaceutical company focused on pharmaceuticals for women,s ... 27th Annual ROTH Conference, which will take place from ... Dana Point, California . Management,s presentation will ... Pacific Time (12:00 p.m. Eastern Time) in the Promenade ...
(Date:3/3/2015)... Spain , March 3, 2015  AT&T 1 ... PHIA) today announced that  AT&T  is the connectivity provider ... GoSafe was designed to help provide peace of mind ... them the freedom to live active lives with the ... they need it. The AT&T network 2 helps ...
(Date:3/3/2015)... -- Today, the Partnership for Prescription Assistance (PPA), ... companies, unveiled a redesigned website with ... caregivers with faster, easier access to information on ... programs. Since its launch in ... educate and empower patients and caregivers to access ...
Breaking Medicine Technology:AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 2AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 3AT&T Providing Connectivity for Philips GoSafe Mobile Medical Alert System, Empowering United States Seniors to be Connected to Emergency Care On-the-Go 4Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2
... N.Y., Sept. 29 International Business ... (MHIN) will jointly present the 7th Annual MidAmerica ... Wisconsin Technology Council. The conference brings together ... corporate business development executives, angel investors, investment bankers, ...
... Aesthetics, a science-based medical device company dedicated to the development ... has announced the appointment of Gordie Nye as ... founder of Zeltiq Aesthetics, who served as President since September ... the Board of Directors since 2006. Mr. Levinson will ...
Cached Medicine Technology:Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 2Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 3Announcing Companies to Present at the 7th Annual MidAmerica Healthcare Venture Forum 4Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 2Zeltiq Aesthetics Names Gordie Nye to Serve as New CEO 3
(Date:3/3/2015)... Dan E. Chambers, an experienced Los Angeles criminal ... recently spoke on the radio to give his insights into ... Independent Journal Review radio show “The Right Mics” chose Chambers ... and now as a criminal defense attorney would provide him ... and sentencing of this high-profile case. , During the ...
(Date:3/3/2015)... In March, 1% for the Planet ... off a new campaign, “Know Your Source,” which calls for ... ambassadors in their quest for ingredient awareness and better business ... its members and partners, including King Arthur Flour, Good Culture, ... raise awareness for food as an environmental issue, with a ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 ... vice president and chief clinical integration and ... System. In this newly established role, Dr. ... the NewYork-Presbyterian Healthcare System physician enterprise, its ... Doctors and Weill Cornell Physicians. , Dr. ...
(Date:3/3/2015)... Daylight Savings Time may lead to your kids to ... parents. , Parents and their children may feel a bit ... set their clocks forward one hour for Daylight Savings Time. ... hour earlier -- you will have already lost one hour ... “sleep hygiene” for their kids and teens this week, says ...
(Date:3/3/2015)... NY (PRWEB) March 03, 2015 ... allege a metal-on-metal version of the artificial hip ... complications continue to move forward in the federal ... District of Texas. According to the most recent ... March 2, 2015, 7,350 Pinnacle hip replacement lawsuits ...
Breaking Medicine News(10 mins):Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 2Health News:Dan E. Chambers Gives Radio Interview Providing Insights into American Sniper Guilty Verdict 3Health News:1% For the Planet Asks Consumers to “Know Your Source” 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 3Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 4Health News:Don’t Let Daylight Savings Disrupt Your Child’s Sleep 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4
... the 2007 third quarter includes $1.8 million of first ... commercial products, DUBLIN, Calif., Oct. 29 SuperGen ... the discovery, rapid,development and commercialization of therapies for solid ... third,quarter and nine months ended September 30, 2007. ...
... should focus on those with first-ever attack, babies, and ... (HealthDay News) -- Immediate CT brain scans should be ... to help doctors determine the right kind of treatment, ... Academy of Neurology. , The guideline authors analyzed all ...
... computer-based method for evaluating the eyes ability to distinguish ... degeneration (AMD) could provide a more accurate way to ... interventions with devices and training, according to a Canadian ... and high-contrast illumination targets for testing spatial vision, which ...
... - Dosage Cup Being Replaced, No Issue with Medicine ... a division of Wyeth (NYSE: WYE ), today ... for all U.S. retail,outlets that sell several Robitussin(R) products ... removal of existing products,with a dosage cup that does ...
... The federal government has,approved all of BlueCross ... Part D product offerings. Enrollment applications,can be accepted ... two PPO plans, Medicare Blue(SM) and,Medicare Blue(SM) Plus; ... prescription drug plans, MedBlue(SM) Rx and MedBlue(SM) Rx,Plus. ...
... It,s been six years,since the nation,s capital ... region were attacked again, are we any better ... of the prestigious Washington Hospital,Center will answer the ... Hotel with "ARE WE READY?" -- as they ...
Cached Medicine News:Health News:SuperGen Reports 2007 Third Quarter Financial Results 2Health News:SuperGen Reports 2007 Third Quarter Financial Results 3Health News:SuperGen Reports 2007 Third Quarter Financial Results 4Health News:SuperGen Reports 2007 Third Quarter Financial Results 5Health News:SuperGen Reports 2007 Third Quarter Financial Results 6Health News:SuperGen Reports 2007 Third Quarter Financial Results 7Health News:SuperGen Reports 2007 Third Quarter Financial Results 8Health News:SuperGen Reports 2007 Third Quarter Financial Results 9Health News:SuperGen Reports 2007 Third Quarter Financial Results 10Health News:Certain Seizure Patients Need Emergency CT Scan 2Health News:Test for visual acuity could aid detection, rehabilitation of AMD 2Health News:Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion 2Health News:Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion 3Health News:Are We Ready? Washington Hospital Center Sets Precedents in Preparedness for 9/11-Style Attacks 2
Ergotec Vetriretinal Instrument System. Ultra-fine 2.8 mm jaws. Angled 55 degrees. 20 gauge shaft. 25 mm in length with black tip. Overall length from rear rotation knob to tip....
Triangular shaped tips. Marked for 5 mm and 10 mm tucks. Round knurled handle with polished finish....
Angled shafts with 12 mm scaled jaws. 1 mm teeth on one jaw fit into holes on the other jaw. Slide lock and serrated handle with polished finish. Left. Most popular size or model....
Angled shafts with 11 mm long tips. Jaws have longitudinal meshing serrations. Slide lock and serrated handle with polished finish....
Medicine Products: